Intercostal Mulligan Moblization Post Mastectomy (NCT07181980) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Intercostal Mulligan Moblization Post Mastectomy
Egypt40 participantsStarted 2025-09-16
Plain-language summary
the study is to evaluate the therapeutic efficacy of intercostal mulligan Mobilization in decreasing pain and improve ROM for shoulder dysfunction Patients post mastectomy.
Who can participate
Age range
40 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients post modified radical mastectomy at least 3 months prior and had a limited ROM in abduction.
* Patients post mastectomy with lateral chest wall pain.
* Age ranges between 40-60 years.
* All patients had informed written consent
Exclusion Criteria:
* Receiving any previous rehabilitation programs for the upper extremities
* The presence of any type of metastases
* The presence of lymphedema
* Bilateral breast cancer surgery
* Locoregional recurrence
* Withdrawal of the consent at any time during the study for any reason
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
range of motion of shoulder abducation Universal goniometer.
Timeframe: Universal goniometer: maximum pain free shoulder abduction was investigated in an upright position .Normal range of active movement of the shoulder 180 degree Were recorded at baseline and at the end of 8 weeks of treatment.
Trial details
NCT IDNCT07181980
SponsorCairo University
Sponsor typeOTHER
Study typeINTERVENTIONAL
Primary completion2026-09-16
Contact for this trial
Amany R lecturer of physical therapy Cairo university, PHD physical therapy